Astellas Pharma increases sales and profits, becomes 1 trillion Yen company

Blockbuster is Vesicare (Solifenacin-succinate), a muscarine receptor blocker for the treatment of overactive bladder

Astellas news release, May 13, 2013

Most popular posts: